glutamine has been researched along with Acute Onset Vascular Dementia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Y; Jiang, H; Li, W; Liu, H; Nie, Z; Pu, X; Sun, Y; Wang, C; Xiong, X; Zhang, K; Zhang, X; Zhao, X | 1 |
Aasly, J; GĂ„rseth, M; Sonnewald, U; White, LR | 1 |
2 other study(ies) available for glutamine and Acute Onset Vascular Dementia
Article | Year |
---|---|
(S)-Oxiracetam is the Active Ingredient in Oxiracetam that Alleviates the Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion in Rats.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Astrocytes; Cerebral Cortex; Cerebrovascular Circulation; Cognitive Dysfunction; Dementia, Vascular; Disease Models, Animal; Glutamic Acid; Glutamine; Male; Neurons; Neuroprotective Agents; Nootropic Agents; Pyrrolidines; Rats; Rats, Wistar; Spatial Learning; Spatial Memory; Stereoisomerism; White Matter | 2017 |
Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Case-Control Studies; Choline; Dementia, Vascular; Female; Glutamine; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease | 2004 |